[HTML][HTML] Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets

P Karakasis, P Theofilis, PK Vlachakis… - International Journal of …, 2024 - mdpi.com
Atrial fibrosis is a hallmark of atrial cardiomyopathy and plays a pivotal role in the
pathogenesis of atrial fibrillation (AF), contributing to its onset and progression. The …

[HTML][HTML] Recent Advances in Understanding the Molecular Mechanisms of SGLT2 Inhibitors in Atrial Remodeling

IA Minciună, R Tomoaia, D Mihăilă, G Cismaru… - Current Issues in …, 2024 - mdpi.com
Atrial cardiomyopathy and remodeling play pivotal roles in the development of atrial
fibrillation (AF) and heart failure (HF), involving complex changes in atrial structure and …

Harnessing SGLT2 Inhibitors: A New Frontier in Cardiac Remodeling for Nondiabetic Heart Failure

CM Martin - Cardiovascular Imaging, 2024 - jacc.org
Sodium-glucose cotransporter-2 (SGLT2) inhibitors have been embraced as a powerful tool
in the heart failure medical therapy armamentarium. Several studies have shown SGLT2 …